NCT07147959View on ClinicalTrials.gov

PET-Based Imaging of Radiolabeled CIT-013

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

December 1, 2026

Conditions

RA

Interventions

DRUG

[89Zr]Zr-CIT

radiolabelled CIT-013

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Citryll BV

INDUSTRY